Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07644195 · ClinicalTrials.gov registry record · Phase 1
Study to Evaluate Safety and Activity of Inhaled TRL1068 in Healthy Volunteers
A Phase 1 study, sponsored by Trellis Bioscience.
- Not yet
- Registry status
- Phase 1
- Development phase
- 14
- Enrollment target
NCT07644195: Clinical Trial Phase 1 study, sponsored by Trellis Bioscience.
NCT07644195 is a Phase 1 study that has not yet begun recruiting, run by Trellis Bioscience. The registered enrollment target is 14 participants, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (77% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07644195, a Phase 1 study, has not yet begun recruiting, sponsored by Trellis Bioscience.
- NOT YET RECRUITING
- Registry status
- Phase 1
- Development phase
- 14 participants
- Enrollment target
Study Summary
This study in healthy volunteers will provide a basis for evaluation of inhaled TRL1068 as a first in human study, specifically, important safety, tolerability, and pharmacokinetic data.
Primary Outcome
Clinically-significant abnormal physical exam findings will be reviewed
Interventions
- DRUG TRL1068, a human monoclonal antibody
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 14 participants |
| Start Date | 2026-10 |
| Est. Completion | 2026-12 |
| Phase | Phase 1 |
What is known before NCT07644195 opens enrollment
NCT07644195 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 14 participants, a relatively small participant target, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (77% lower).
The record links to 0 conditions, and to 1 intervention - of which TRL1068, a human monoclonal antibody is the first listed.
NCT07644195 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07644195 about?
NCT07644195 is a clinical study titled "Study to Evaluate Safety and Activity of Inhaled TRL1068 in Healthy Volunteers". This study in healthy volunteers will provide a basis for evaluation of inhaled TRL1068 as a first in human study, specifically, important safety, tolerability, and pharmacokinetic data.
What is the current status of trial NCT07644195?
This trial is currently not yet recruiting. It is a Phase 1 study. The enrollment target is 14 participants. The study started on 2026-10. Estimated completion is 2026-12.
What interventions are being tested in trial NCT07644195?
The interventions under investigation include: TRL1068, a human monoclonal antibody (DRUG).
Who is sponsoring clinical trial NCT07644195?
This trial is sponsored by Trellis Bioscience, which has 4 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07644195's enrollment target sits among peer trials
14 1844th of 2000 higher than 154 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02523092 · 14 participants · Phase 4
Use of CXCL9 as a Biomarker of Acthar Efficacy
- NCT04263285 · 14 participants · NA
Treatment of Depression Post-SCI
- NCT04743271 · 14 participants · NA
Food and Circadian Timing
- NCT05065671 · 14 participants · Phase 1
Microbiome Derived Metabolism and Pharmacokinetics
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia